United States · Biotechnology startup
United States · Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Funding reportedLast round: Series B
What company datasets say Celsius Therapeutics raised
Funding, as reported
Reported in all$148Min dollars
Rounds2
Last roundSeries B
Last round dateMar 2022
Investors listed12
SEC Form D$62M sold, 2 filings, last Oct 2019
Founders and team
From the SEC filings it signed: 3 on the team.
- Christoph LengauerExecutive Officer, Directori
- Michael BorettiExecutive Officeri
- Tariq KassumExecutive Officer, Directori
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Celsius Therapeutics in front of investors. Or tell us what we have wrong.